Knipp lab: Difference between revisions
DeEtte Starr (talk | contribs) mNo edit summary |
DeEtte Starr (talk | contribs) mNo edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ | {{Template:Knipp}} | ||
<div style="padding: 10px; width: 720px; border: 5px solid #CC9933;"> | <div style="padding: 10px; width: 720px; border: 5px solid #CC9933;"> | ||
<strong><font size="+2">W</font>elcome!</strong> | <strong><font size="+2">W</font>elcome!</strong> | ||
<p align="left"> Dr. Gregory Knipp's research interests include the molecular and functional characterization of oligopeptide transporters, where he has been focusing on the characterization of the human Peptide/Histidine Transporter 1 isoform in human intestinal and blood brain barrier cell lines. He is interested in determining the effect of xenobiotics, particularly delineating the roles of DEHP and Bisphenol A, on placental fatty acid homeostasis and fetal development. He has also been interested in investigating the effects of processing induced dosage form variation on clinical performance utilizing in vitro and in vivo (porcine) models. His recent work has focused on the utilization of the porcine model for testing the pharmacokinetics of adult and novel pediatric formulations developed within his laboratory. </p> | <p align="left">Dr. Gregory Knipp's research interests include the molecular and functional characterization of oligopeptide transporters, where he has been focusing on the characterization of the human Peptide/Histidine Transporter 1 isoform in human intestinal and blood brain barrier cell lines. He is interested in determining the effect of xenobiotics, particularly delineating the roles of DEHP and Bisphenol A, on placental fatty acid homeostasis and fetal development. He has also been interested in investigating the effects of processing induced dosage form variation on clinical performance utilizing in vitro and in vivo (porcine) models. His recent work has focused on the utilization of the porcine model for testing the pharmacokinetics of adult and novel pediatric formulations developed within his laboratory. </p> | ||
<em>Click the links above to learn more about our research, our group members and our recent activities. Thanks for visiting!</em> | <em>Click the links above to learn more about our research, our group members and our recent activities. Thanks for visiting!</em> | ||
Revision as of 08:14, 26 November 2013
Welcome!
Dr. Gregory Knipp's research interests include the molecular and functional characterization of oligopeptide transporters, where he has been focusing on the characterization of the human Peptide/Histidine Transporter 1 isoform in human intestinal and blood brain barrier cell lines. He is interested in determining the effect of xenobiotics, particularly delineating the roles of DEHP and Bisphenol A, on placental fatty acid homeostasis and fetal development. He has also been interested in investigating the effects of processing induced dosage form variation on clinical performance utilizing in vitro and in vivo (porcine) models. His recent work has focused on the utilization of the porcine model for testing the pharmacokinetics of adult and novel pediatric formulations developed within his laboratory.
Click the links above to learn more about our research, our group members and our recent activities. Thanks for visiting!
<html>Hosted by <a href="http://www.openwetware.org"><img src="http://openwetware.org/images/0/01/80x15_openwetware.png" border="0" /></a></right> </html>
